tirzepatide patent expiry india Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute India's Semaglutide Revolution: Weight Loss

2024 June 12

Talk with a doctor if you have questions about using supplements for weight loss or would like help losing weight.

Endocrine, 14 (1), 7986

The safety data over 48 weeks was equally reassuring for those considering long-term treatment

When Compounded May Be Appropriate According to federal guidelines and the company's disclosures, compounded tirzepatide may be appropriate when: Insurance denies coverage, and you cannot afford $1,000+/month out-of-pocket for brand-name Brand-name medications are unavailable due to shortages You meet medical criteria (BMI 30+ or 27+ with comorbidities) but cannot access FDA-approved options Your prescriber determines that the compounded preparation offers meaningful access where approved products are not feasible for you The evaluating clinician determines whether compounded tirzepatide is appropriate based on individual health factors, access barriers, and medical necessity